Blockchain Registration Transaction Record

HeartBeam Enrolls First Patients in Groundbreaking Heart Attack Detection Study

HeartBeam begins ALIGN-ACS pilot study for heart attack detection using revolutionary 3D ECG technology. First patients enrolled in Serbia for clinical trial expansion beyond arrhythmia assessment.

This development represents a potential paradigm shift in cardiac care that could save lives by enabling earlier heart attack detection outside hospital settings. Heart attacks remain a leading cause of death worldwide, with delayed diagnosis contributing significantly to poor outcomes. Current ECG technology typically requires hospital visits and specialized equipment, creating barriers to timely intervention. HeartBeam's portable 3D ECG system could democratize access to sophisticated cardiac monitoring, allowing for earlier detection during critical moments when every minute counts. For patients with cardiac risk factors, this technology could provide peace of mind through continuous monitoring, while for healthcare systems, it could reduce emergency room visits and hospitalizations through better preventive care. The successful expansion of this technology from arrhythmia to heart attack detection could fundamentally change how we approach cardiac emergencies, moving from reactive treatment in hospitals to proactive monitoring in daily life.